Home
1M
1Y
3Y
5Y
Date | |
---|---|
20 Jan 2025 | 6949.85 |
17 Jan 2025 | 6913.95 |
16 Jan 2025 | 6796.1 |
15 Jan 2025 | 6731.95 |
14 Jan 2025 | 7030.35 |
13 Jan 2025 | 7043.7 |
10 Jan 2025 | 6912.5 |
09 Jan 2025 | 7076 |
08 Jan 2025 | 6892.55 |
07 Jan 2025 | 7092.85 |
Happiest Minds Technologies Ltd, Campus Activewear Ltd, Cera Sanitaryware Ltd, ITI Ltd are among the
Read more
undefined undefined 30
This approval establishes the use of Olaparib in combination with Durvalumab as a maintenance treatm
Read more
undefined undefined 26
Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and market per
Read more
undefined undefined 19
Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter ended 30 Sep
Read more
undefined undefined 14
Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 13 November
Read more
undefined undefined 25
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI
Read more
undefined undefined 24